Cargando…
5613260 A PHASE -- IIA-IIB, OPEN LABEL, SINGLE CENTER TRIAL TO STUDY SAFETY, TOLERABILITY AND EFFICACY OF MEMANTINE AS SUPPORTIVE LONG-TERM TREATMENT OF SICKLE CELL PATIENTS: TRIAL DESIGN AND ENROLLMENT
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10112626/ http://dx.doi.org/10.1097/01.HS9.0000928448.56489.99 |
| _version_ | 1785027662851342336 |
|---|---|
| author | Levin, C.L. Koren, A.K. Peretz, S.S.P. Livshits, L.L. Makhro, A.M. Bogdanova, A.B. Gassmann, M.G. |
| author_facet | Levin, C.L. Koren, A.K. Peretz, S.S.P. Livshits, L.L. Makhro, A.M. Bogdanova, A.B. Gassmann, M.G. |
| author_sort | Levin, C.L. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10112626 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-101126262023-04-19 5613260 A PHASE -- IIA-IIB, OPEN LABEL, SINGLE CENTER TRIAL TO STUDY SAFETY, TOLERABILITY AND EFFICACY OF MEMANTINE AS SUPPORTIVE LONG-TERM TREATMENT OF SICKLE CELL PATIENTS: TRIAL DESIGN AND ENROLLMENT Levin, C.L. Koren, A.K. Peretz, S.S.P. Livshits, L.L. Makhro, A.M. Bogdanova, A.B. Gassmann, M.G. Hemasphere e-Poster Presentations Lippincott Williams & Wilkins 2023-04-10 /pmc/articles/PMC10112626/ http://dx.doi.org/10.1097/01.HS9.0000928448.56489.99 Text en Copyright © 2023 the Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the European Hematology Association. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | e-Poster Presentations Levin, C.L. Koren, A.K. Peretz, S.S.P. Livshits, L.L. Makhro, A.M. Bogdanova, A.B. Gassmann, M.G. 5613260 A PHASE -- IIA-IIB, OPEN LABEL, SINGLE CENTER TRIAL TO STUDY SAFETY, TOLERABILITY AND EFFICACY OF MEMANTINE AS SUPPORTIVE LONG-TERM TREATMENT OF SICKLE CELL PATIENTS: TRIAL DESIGN AND ENROLLMENT |
| title | 5613260 A PHASE -- IIA-IIB, OPEN LABEL, SINGLE CENTER TRIAL TO STUDY SAFETY, TOLERABILITY AND EFFICACY OF MEMANTINE AS SUPPORTIVE LONG-TERM TREATMENT OF SICKLE CELL PATIENTS: TRIAL DESIGN AND ENROLLMENT |
| title_full | 5613260 A PHASE -- IIA-IIB, OPEN LABEL, SINGLE CENTER TRIAL TO STUDY SAFETY, TOLERABILITY AND EFFICACY OF MEMANTINE AS SUPPORTIVE LONG-TERM TREATMENT OF SICKLE CELL PATIENTS: TRIAL DESIGN AND ENROLLMENT |
| title_fullStr | 5613260 A PHASE -- IIA-IIB, OPEN LABEL, SINGLE CENTER TRIAL TO STUDY SAFETY, TOLERABILITY AND EFFICACY OF MEMANTINE AS SUPPORTIVE LONG-TERM TREATMENT OF SICKLE CELL PATIENTS: TRIAL DESIGN AND ENROLLMENT |
| title_full_unstemmed | 5613260 A PHASE -- IIA-IIB, OPEN LABEL, SINGLE CENTER TRIAL TO STUDY SAFETY, TOLERABILITY AND EFFICACY OF MEMANTINE AS SUPPORTIVE LONG-TERM TREATMENT OF SICKLE CELL PATIENTS: TRIAL DESIGN AND ENROLLMENT |
| title_short | 5613260 A PHASE -- IIA-IIB, OPEN LABEL, SINGLE CENTER TRIAL TO STUDY SAFETY, TOLERABILITY AND EFFICACY OF MEMANTINE AS SUPPORTIVE LONG-TERM TREATMENT OF SICKLE CELL PATIENTS: TRIAL DESIGN AND ENROLLMENT |
| title_sort | 5613260 a phase -- iia-iib, open label, single center trial to study safety, tolerability and efficacy of memantine as supportive long-term treatment of sickle cell patients: trial design and enrollment |
| topic | e-Poster Presentations |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10112626/ http://dx.doi.org/10.1097/01.HS9.0000928448.56489.99 |
| work_keys_str_mv | AT levincl 5613260aphaseiiaiibopenlabelsinglecentertrialtostudysafetytolerabilityandefficacyofmemantineassupportivelongtermtreatmentofsicklecellpatientstrialdesignandenrollment AT korenak 5613260aphaseiiaiibopenlabelsinglecentertrialtostudysafetytolerabilityandefficacyofmemantineassupportivelongtermtreatmentofsicklecellpatientstrialdesignandenrollment AT peretzssp 5613260aphaseiiaiibopenlabelsinglecentertrialtostudysafetytolerabilityandefficacyofmemantineassupportivelongtermtreatmentofsicklecellpatientstrialdesignandenrollment AT livshitsll 5613260aphaseiiaiibopenlabelsinglecentertrialtostudysafetytolerabilityandefficacyofmemantineassupportivelongtermtreatmentofsicklecellpatientstrialdesignandenrollment AT makhroam 5613260aphaseiiaiibopenlabelsinglecentertrialtostudysafetytolerabilityandefficacyofmemantineassupportivelongtermtreatmentofsicklecellpatientstrialdesignandenrollment AT bogdanovaab 5613260aphaseiiaiibopenlabelsinglecentertrialtostudysafetytolerabilityandefficacyofmemantineassupportivelongtermtreatmentofsicklecellpatientstrialdesignandenrollment AT gassmannmg 5613260aphaseiiaiibopenlabelsinglecentertrialtostudysafetytolerabilityandefficacyofmemantineassupportivelongtermtreatmentofsicklecellpatientstrialdesignandenrollment |